Daily Newsletter

19 July 2024

Daily Newsletter

19 July 2024

HeartFlow launches plaque analysis platform for coronary artery disease

The new platform provides clinicians with a non-invasive solution to quantify and characterise plaque in the coronary arteries.

Archana Rani July 19 2024

HeartFlow has launched the next-generation interactive HeartFlow Plaque Analysis platform, which is designed to enhance clinical decision-making in assessing patient risk in suspected coronary artery disease (CAD).

The advanced tool integrates with FFRᴄᴛ to offer a comprehensive view of a patient's plaque burden, enabling personalised treatment plans.

The new HeartFlow Plaque Analysis platform provides clinicians with a non-invasive solution to quantify and characterise plaque in the coronary arteries.

By analysing CT angiogram (CCTA) scans, the platform creates a detailed 3D model of the arteries, offering insights into the volume and type of plaque present.

The integration of plaque quantification with lesion-specific FFRᴄᴛ values is a key feature of the interactive experience.

It presents a 3D plaque model and comprehensive analysis, covering various plaque types such as calcified, non-calcified, and low attenuation.  

The platform allows for displaying cross-sectional, colour-coded images of each plaque type along the vessel.

HeartFlow said the Plaque Analysis is recognised for its high level of accuracy, with a 95% agreement for total plaque volume measures when compared to the gold standard IVUS.

HeartFlow chief medical officer Campbell Rogers said: “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment. Our new interactive plaque experience marks an exciting era in AI-enabled cardiac technology, where we are now the only company that offers a fully integrated view of a patient’s true burden of coronary artery disease.

“The elevated visualisation of Plaque Analysis integrated with our flagship FFRᴄᴛ Analysis, sets HeartFlow apart as a wholistic solution for CT analysis, enabling physicians to enhance personalised treatment decisions.”

Uncover your next opportunity with expert reports

Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close